drugset / Trial / NCT00475800
Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This 39-week, open label study is designed to assess long-term efficacy, safety and tolerability of lumiracoxib 100mg od in patients with osteoarthritis (OA) of the knee who participated in the 13-week core CCOX189A2360 study.
Timeline
- Start
- 2004-01
- Primary completion
- 2004-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lumiracoxib | Small molecule | 100 mg | — |